TETRAN Activators
TETRAN activators belong to a unique class of chemical compounds that are of significant interest in the field of molecular biology and biochemistry. The name "TETRAN" refers to a specific structural motif or functional group within these molecules that is critical to their activity. Typically, TETRAN activators are characterized by their ability to modulate specific biological processes by interacting with particular molecular pathways or binding to target proteins. These interactions are often highly specific, as the TETRAN activators are designed or discovered based on their ability to engage with distinct molecular structures or conformations. The precise nature of the interaction between TETRAN activators and their targets can vary widely, depending on the chemical structure of the activator and the biological context in which it is active.
The development and study of TETRAN activators involve advanced chemistry techniques, including organic synthesis, computational modeling, and various analytical methods to ascertain their structure, purity, and stability. Researchers interested in these compounds must also have a deep understanding of molecular dynamics and kinetics, as the effectiveness of TETRAN activators is often linked to their ability to reach and maintain sufficient concentrations at their sites of action within a given environment. The specificity of TETRAN activators is not only a function of their chemical structure but also of the spatial and temporal patterns of their interaction with target molecules. As with many activators in biochemical systems, TETRAN compounds may also exhibit a range of activities based on their concentration, the presence of other molecules that can modulate their function, and the overall physicochemical conditions of their surroundings. This level of complexity requires a multidisciplinary approach to fully elucidate the characteristics and behavior of TETRAN activators in their relevant contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin acts by elevating intracellular cAMP levels, which in turn activates PKA. Upon activation, PKA can phosphorylate various substrates including those involved in signaling pathways that TETRAN is a part of, leading to its functional enhancement. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in numerous signaling cascades. TETRAN activity is enhanced as PKC activation can lead to downstream signaling events that include TETRAN as a participant or effector. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule activates G protein-coupled receptors, which can lead to a cascade of intracellular signaling events. These events can modulate the activity of TETRAN by altering its signaling environment. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cell-permeable cAMP analog that directly stimulates cAMP-dependent pathways, thereby activating PKA. PKA activation can then enhance TETRAN activity by phosphorylating substrates that interact with or regulate TETRAN. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium levels, which subsequently activates calcium-dependent signaling pathways. These pathways can include those that enhance the function of TETRAN. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Another calcium ionophore that raises intracellular calcium concentration. The increase in calcium can enhance TETRAN activity by activating calcium-dependent proteins that may interact with or regulate TETRAN. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, LY294002 can shift signaling pathways by inhibiting PI3K-dependent pathways, indirectly leading to the enhancement of TETRAN activity via alternative signaling routes that TETRAN is involved in. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Similar to LY294002, Wortmannin is also a PI3K inhibitor. By reducing PI3K signaling, TETRAN-associated pathways may become more prominent, resulting in enhanced TETRAN activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a tyrosine kinase inhibitor that can modulate kinase signaling pathways. By inhibiting competitive kinase activity, pathways that enhance TETRAN function may be upregulated. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK1/2, U0126 can lead to a reduction in MAPK/ERK pathway signaling. This modulation may shift the balance of signaling towards pathways that upregulate TETRAN activity. | ||||||